English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduYounger adults living in the U.S. are less likely to be screened for colorectal cancer than older U.S. adults, despite now being eligible under new screening guidelines, and face greater disparities than older U.S. adults who are eligible for screening, according to research from UTHealth Houston.
Tag: Colorectal Cancer
Listeria-based Booster Improves Vaccine’s Protection Against Recurring Colon Cancer
New research in mice from Thomas Jefferson University has paved the way for a Phase I clinical trial and has the potential to transform vaccines against HIV and malaria.
Roswell Park Researchers Identify Molecular ‘Glue’ That Sticks to and Degrades a Cancer-Causing Protein
A small molecule discovered and developed by a team of scientists led by Fengzhi Li, PhD, Associate Professor of Oncology in the Department of Pharmacology and Therapeutics at Roswell Park Comprehensive Cancer Center, eliminates human pancreatic and colorectal tumor cells by binding to and degrading DDX5, a powerful cancer-causing protein.
Study Finds COVID-19 Pandemic Reduced Breast, Cervical, Colorectal Cancer Screenings by Millions in 2020
New findings led by researchers at the American Cancer Society show the number of women in the United States who reported having a recent (in the past year) breast cancer or cervical cancer screening dropped by 2.13 million (6%) and 4.47 million (11%) respectively in 2020 compared to 2018. The study is the first of its kind to evaluate the impact of the COVID-19 pandemic on cancer screenings nationally using population-based data.
Zulu Social Aid and Pleasure Club Presents Men’s Health Fair, Sponsored by Ochsner Xavier Institute of Health Equity and Research
Zulu Social Aid and Pleasure Club Presents Men’s Health Fair, Sponsored by Ochsner Xavier Institute of Health Equity and Research.
DeepGI AI – A Thai Innovation for the Precision in Colorectal Polyp Detection
Chula Engineering and Chula Medicine co-invent an innovative device for a rapid gastrointestinal cancer detection that yields accurate results hoping to foster preventive medicine in gastrointestinal malignancy and reduce the number of cancer patients.
New Research Finds Computer Assisted Colonoscopy Identify More Precancerous Polyps Compared to Traditional Colonoscopy
Colonoscopies performed with artificial intelligence saw an increase in the overall rate of detection of adenoma, or cancerous and precancerous polyps, according to new data presented at the 2022 Digestive Disease Week Annual Meeting.
Nurses Week: Cancer Survivor Karla Lopez, RN, Goes Above and Beyond
Karla Lopez was nearing the end of her first year of nursing school when she was diagnosed with colorectal cancer. It was a scary setback, but she wouldn’t let it stop her. “I wanted to become an amazing nurse,” she said, “so I fought through and … here I am a pediatric nurse.” Video Available.
Does Multiple Sclerosis Play a Role in Cancer Screening and Diagnosis?
Women with multiple sclerosis (MS) are less likely to have breast cancers detected through cancer screenings than women without MS, according to new research published in the April 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. Conversely, researchers also found that people with MS are more likely to have colorectal cancers detected at an early stage than those without MS.
MD Anderson Research Highlights: SITC 2021 Special Edition
This special edition of MD Anderson’s Research Highlights features presentations at the Society for Immunotherapy of Caner 36th Annual Meeting.
November Issue of The American Journal of Gastroenterology Discusses Association Between BMI and Early-Onset Colorectal Cancer Risk, PPIs and All-Cause Mortality
The November issue of The American Journal of Gastroenterology features several articles examining the association between common conditions or treatments and the risk for disease development, including a study on the association between higher body mass index and increased risk for early-onset colorectal cancer, and a population study on proton pump inhibitors and all-cause mortality.
Best-Selling Cookbook Author Sarah Copeland Hosts Cooking Demonstration for the Colorectal Cancer Community
Fight Colorectal Cancer Hosts Gut-Friendly Cooking Event Alongside Best-Selling Cookbook Author and Former Food Director at Real Simple.
Survival similar for younger and older patients with metastatic colorectal cancer, study finds
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
Low vitamin D status may lead to elevated colorectal cancer risk in black women
They found that, among Black women, those whose predicted vitamin D levels were low (in the bottom 25 percent of all participants) were estimated to have a 40 percent higher risk of developing colorectal cancer compared with women whose predicted levels were in the top 25 percent.
New Clinical Advances in Gastroenterology Presented at the American College of Gastroenterology’s 86th Annual Scientific Meeting
Featured science includes increased incidence of pancreatic cancer among young women, quality of life improvements in IBD, colorectal cancer risk from weight loss surgery and medications, and more
COVID-19 pandemic shifted patient attitudes about colorectal cancer screening
For people hesitant to come into the hospital or an outpatient center to get a colonoscopy, home-administered fecal occult blood tests (FOBT) may provide a useful workaround tool.
New Noninvasive Tests for Colon and Prostate Cancer Presented at the 2021 AACC Annual Scientific Meeting
Two research teams have developed new noninvasive tests that use either blood or saliva samples to diagnose cases of colorectal cancer or prostate cancer, respectively. Presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, these tests could facilitate screening efforts for colorectal cancer and allow clinicians to better distinguish early-stage prostate cancer from more benign prostate conditions.
New study shows that different types of cancers are likely to spread to specific areas of the brain
Brain metastasis occurs when cancer in one part of the body spreads to the brain. The lifetime incidence of such metastatic brain tumors in cancer patients is between 20%-45%, research shows.
Cleveland Clinic Launches Center for Young-Onset Colorectal Cancer
Cleveland Clinic has established a center focused on the diagnosis, care, and research of young-onset colorectal cancer.
First-of-its-kind study: Use of computer-assisted colonoscopies reduces rate of missed lesions
In the first randomized trial examining the role of a deep-learning based computer-aided detection system during colonoscopy in the U.S., researchers reported a relative reduction of the miss rate by nearly a third when computer-aided detection was used in conjunction with standard-of-care colonoscopy.
Maternal obesity during pregnancy linked to higher risk of colorectal cancer in adult offspring
Infants whose mothers were obese during pregnancy may have a heightened risk of developing colorectal cancer later in life, according to new research led by public health experts at The University of Texas Health Science Center at Houston (UTHealth).
Mechanism for Development of Rare Colorectal Cancer Subtype Identified
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, recently discovered a mechanism to explain what drives the formation of mucinous colorectal adenocarcinoma (MAC), a rare subtype of colorectal cancer.
Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic
Selected Recipients of the New “Back to Screening Award for Research Advocacy Excellence” will be Honored at Fight Colorectal Cancer’s “Path to a Cure” Event in December 2021.
Colorectal Cancer Risk May Increase with Lower Exposure to UVB Light
University of California San Diego School of Medicine researchers identified a possible link between inadequate exposure to ultraviolet-B (UVB) light from the sun and an increased risk of colorectal cancer.
Tumor cell PD-L1 may mediate sensitivity to chemotherapy in colorectal cancer treatment
Data in a study by Mayo Clinic Cancer Center researchers indicates that the level of tumor cell PD-L1, a protein that acts as a brake to keep the body’s immune responses under control, may be an important factor for sensitivity to chemotherapy in colorectal cancer treatment. The study was published Friday, July 2, in Oncogene.
New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer
New and updated patient and caregiver resources from National Comprehensive Cancer Network (NCCN) offer jargon-free, state-of-the-art information on diagnosis, treatment, and surveillance for anal, colon, and rectal cancers.
Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine
NEWS STORIES IN THIS ISSUE:
– Study Says Failure to Rid Amyloid Beta Protein from Brain May Lead to Alzheimer’s Disease
– Johns Hopkins Medicine Team Discovers Novel Mediator of Once Mysterious Chronic Itch – Study Suggests Molecular Changes in Tissue Microenvironment May Promote Colorectal Cancer
– Researchers ID Anti-Inflammatory Proteins as Therapy Targets for Nasal and Sinus Problem
– Johns Hopkins Children’s Center Receives NIH Award to Study Dangerous Pediatric Disease
Global Event Will Advance Early Age Onset Colorectal Cancer Research
In many countries around the world, patients under age 50 are fighting, some dying, of colon and rectal cancers. Early-Age Onset Colorectal Cancer is an urgent issue in cancer research and patient care around the globe. We all want to know why this is happening, fully aware that for some, time is running out.
Why Is Lowering The Colorectal Cancer Screening Age to 45 A Big Deal?
Today, the United States Preventive Services Task Force (USPSTF) finalized its recommendation to adapt the colorectal cancer (CRC) screening guidelines and lower the age to begin screening to 45 instead of 50. “Shifting current age-specific screening rates to five years…
Experts available to discuss new USPSTF recommendation to lower age for regular colorectal cancer screenings to 45
Michigan Medicine experts are available to discuss the U.S. Preventive Services Task Force’s new final recommendation that people with no symptoms and an average risk of developing colorectal cancer begin regular colorectal cancer screenings at age 45 instead of 50,…
Mental Health Support: Study Reveals Huge Need Amongst Colorectal Cancer Patients
This Mental Health Awareness Month, Fight Colorectal Cancer, is urging the clinician and patient communities to take mental health seriously and connect patients with resources.
Nanotechnology offers new hope for bowel cancer patients
Bowel cancer is the second deadliest cancer in the world, killing almost 900,000 people in 2020. New research from Indian and Australian scientists suggests that nanotechnology could provide a more effective treatment option than conventional therapy.
Patient reactions to colorectal cancer estimated to become the leading cause of cancer-related deaths for those 20-49 by 2030
In a recent JAMA publication, researchers predict, “For the age group 20-49, colorectal cancer was estimated to become the leading cause of cancer-related deaths by 2030.” Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization, is committed to amplifying…
Mayo study finds colon cancer driven by hereditary gene mutations in 1 in 6 patients
A new Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.
MD Anderson and TriSalus Life Sciences announce strategic research collaboration to evaluate treatment of solid tumors
MD Anderson and TriSalus announced a strategic research collaboration to evaluate the treatment of liver and pancreas tumors with the investigational therapy SD-101 in combination with immunotherapy using a novel delivery approach.
NYU Langone Seeks to Close the Gap in Colorectal Cancer Disparities with $2.2 Million Cohen Foundation Grant
NYU Langone Health will expand colorectal cancer screenings to address disease disparities in underserved communities with a $2.2 million grant from the Steven & Alexandra Cohen Foundation.
Rock Musicians Rufus Wainwright, Lisa Loeb, Tim Reynolds and More to Perform Free Virtual Concert for Colorectal Cancer Awareness
The American College of Gastroenterology Invites All to “Tune It Up: A Concert To Raise Awareness of Colorectal Cancer” Free Webstream Event Open to All on March 31, 2021 at 8:00 pm EDT
Baby Aspirin Linked to Lower Risk of Colorectal Cancer Death
Long-term, regular use of baby aspirin—at least 15 times per month—prior to a diagnosis of colorectal cancer (CRC) may reduce the risk of death from the disease by limiting the spread of cancerous tumors pre-diagnosis, according to a study led by Cedars-Sinai Cancer researchers.
Drug used during pregnancy may increase cancer risk in mother’s adult children
Exposure in the womb to a drug used to prevent miscarriage appears to raise the offspring’s cancer risk decades later, especially for colorectal and prostate cancers, researchers have found. They will present the results of their new study Tuesday at ENDO 2021, the Endocrine Society’s annual meeting.
GI OnDEMAND Announces Partnership with Ambry Genetics for Genetic Testing and Counseling Services
GI OnDEMAND®, gastroenterology’s leading multidisciplinary virtual integrated care platform today announced a partnership with Ambry Genetics®, a leading clinical genetic testing company, to integrate online genetic counseling and testing services into gastroenterology practices nationwide. This partnership addresses a critical clinical need for identifying hereditary GI cancer syndromes to help guide potentially life-altering health care decisions.
GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer the CARE (Comprehensive, Assessment, Risk, and Education) Program™ from Ambry Genetics.
UVA Health’s Dr. Cynthia Yoshida Honored Nationally for Increasing Colorectal Cancer Screenings
UVA Health’s Cynthia M. Yoshida, MD, is one of six winners of a national award recognizing healthcare providers and institutions for their work to increase colorectal cancer screening rates.
American College of Gastroenterology Issues Updated Colorectal Cancer Screening Guidelines
The American College of Gastroenterology has issued updated evidence-based screening guidelines for colorectal cancer (CRC), including a new recommendation to begin CRC screening at age 45 for average risk adults. Key updates include recommendations for screening individuals with family history of CRC or polyps, guidance on the use of aspirin to reduce the risk of CRC, quality indicators for adenoma detection rate and colonoscopy withdrawal time, as well as suggestions about evidence-based interventions to boost screening rates, especially among African Americans. The authors distinguish between one-step screening tests, such as colonoscopy, and two-step screening tests that require colonoscopy, if positive, in order to complete the screening process.
The Medical Minute: Colonoscopy comes calling earlier under new screening guidelines
Evolving evidence shows screening tests should actually start at age 45 for people at average risk for colorectal cancer. Two Penn State Health doctors discuss new guidelines.
Colonoscopy: Yes, This is a Test
Colorectal cancer is the second leading cause of cancer death for both men and women, according to the Centers for Disease Control and Prevention (CDC), even though 90 percent of people who are diagnosed through early testing can be cured.
Putting the Spotlight on Colorectal Cancer Risk and Prevention during Colorectal Cancer Awareness Month
Colorectal Cancer Screening Saves Lives Colorectal cancer is the third most common cause of cancer related death for both men and women. However, if it is caught early, colorectal cancer has a 90% survival rate. This is why screening is…
UCLA expert available to discuss colorectal cancer screening prevention, more during Colorectal Cancer Awareness Month
Folasade May, MD, PhD, UCLA Health colon cancer prevention researcher and gastroenterologist, is available for interview on a variety of topics during colorectal cancer awareness month, including: Why it’s so important to not skip colorectal cancer screenings — even though…
Cancer Cell Vulnerability Points to Potential Treatment Path for Aggressive Disease
New findings, reported in Nature Communications, describe the discovery of a unique dependence of cancer cells on a particular protein, which could lead to desperately needed treatment for hard-to-treat cancers.
Liquid biopsy for colorectal cancer could guide therapy for tumors
A new study from Washington University School of Medicine in St. Louis demonstrates that a liquid biopsy examining blood or urine can help gauge the effectiveness of therapy for colorectal cancer that has just begun to spread beyond the original tumor. Such a biopsy can detect lingering disease and could serve as a guide for deciding whether a patient should undergo further treatments.
MD Anderson and Mirati Therapeutics announce KRAS strategic research and development collaboration in solid tumors
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati’s two investigational small molecule, potent and selective KRAS inhibitors – adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents – which target two of the most frequent KRAS mutations in cancer.
Take-At-Home Tests Boost Colorectal Cancer Screening Tenfold for Health Center Serving Minorities
By making it the default to send colorectal cancer screening tests to patients’ homes unless they opted out via text message, screening rates increased by more than 1,000 percent